Tampa, Florida-based TuHURA Biosciences has completed its acquisition of Kineta, Inc., adding a Phase 2-ready VISTA-inhibiting monoclonal antibody to its pipeline of cancer immunotherapy treatments designed to overcome resistance mechanisms that limit current therapies. Key Points The acquisition positions TuHURA […]
The employee wellbeing services market sees significant consolidation as Canadian telecommunications giant TELUS Corporation moves to expand its healthcare technology portfolio. TELUS Health announced the acquisition of Workplace Options, a provider of employee assistance programs serving Fortune 500 companies across
TELUS Health Acquires Workplace Options in $500 Million Deal Read More »
Brii Biosciences has secured complete ownership of BRII-179, a hepatitis B immunotherapy candidate, through an $18 million acquisition from VBI Vaccines and its creditors. The acquisition gives Brii full control over intellectual property, manufacturing, and supply while eliminating future milestone
Brii Biosciences BRII-179 Acquisition Read More »
A Canadian healthcare acquisition company is continuing to build its portfolio of healthcare technology companies. Principal Technologies Inc. announced on December 11, 2024, that it signed a non-binding letter of intent to acquire a 70.7% controlling interest in Syndermix AG,
A medical device company specializing in joint preservation has changed ownership, returning to management by its former executives. Arthrosurface, Inc., which develops joint restoration solutions for active patients, was acquired from Anika Therapeutics (NASDAQ: ANIK) by a group led by
Los Angeles-based M&A Healthcare Advisors (MAHA) are now registered agents of Finalis, a broker-dealer regulated by the Financial Industry Regulatory Authority (FINRA). This new development enhances the advisory group’s service offerings in the healthcare industry. Key Points MAHA’s new status
M&A Healthcare Advisors Expands Dealmaking Capabilities Read More »
